Table 1.

ERG a-wave and b-wave data from CNTF- and PBS-treated rats

Treatmenta-wave amplitudea (μV)b-wave Vmaxb (μV)b-wave kb (log cd · s/m2)a-wave CNTF/PBS ratiob-wave CNTF/PBS ratio
6 d
    PBS (n = 8)584 ± 81p < 0.011543 ± 224p < 0.05−3.50 ± 0.10p < 0.050.38 ± 0.09p < 0.010.59 ± 0.12p < 0.05
    CNTF (n = 8)194 ± 44774 ± 165−3.08 ± 0.09
21 d
    PBS (n = 8)466 ± 77NS1116 ± 134NS−3.42 ± 0.06NS1.08 ± 0.16NS1.03 ± 0.16NS
    CNTF (n = 8)438 ± 541063 ± 132−3.36 ± 0.05
  • aAmplitude at the maximum intensity (0.6 log cd · s/m2).

  • bNaka–Rushton function fit to scotopic b-wave data.

  • Values are mean ± SEM. p values were calculated using the repeated-measures two-way ANOVA (matching across time), followed by the Bonferroni's post hoc test for specific comparisons. For a-wave amplitude and b-wave Vmax, raw amplitudes were used. For ratios, values were first converted to logarithms to convert the differences to ratios. The log intensity values were used to calculate the p values for k. All measurements showed a significant effect of treatment (p < 0.01, a-wave; p < 0.05, b-wave and k) overall and interaction of time and treatment (p < 0.05) but no significant effect of time.